510(k) · Cleared
ClearedModified Trevo Retriever
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Concentric Medical, Inc. · NRY Catheter, Thrombus Retriever
Cleared on Oct 31, 2012 as substantially equivalent to K120961 (Concentric Medical, Inc., 2012) after a 78-day review. Its family tree reaches back 5 generations to 2001. 10 later devices descend from it.
- Decided
- Oct 31, 2012
- Review
- 78 days
- Class
- Class II
- Product code
- NRY
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 5 generations to K003410 (2001). 6 ancestors in all. 10 later devices descend from it, 3 citing it directly.
- Root · 5 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
- 4 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
- 3 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
- 2 generations backK063774 Modification to Merci Retriever, Models X5 and X6Concentric Medical, Inc. · 2007
- 1 generation backK120961 Trevo RetrieverConcentric Medical, Inc. · 2012 · Recalled
- This deviceK122478 Modified Trevo RetrieverConcentric Medical, Inc. · 2012
- Descendant · cites it directly · 4 of its ownK173452 EmboTrap ll Revascularization DeviceNeuravi, Ltd. · 2018
- Descendant · 2 generations on · 3 of its ownK193063 EMBOTRAP III Revascularization DeviceNeuravi, Ltd. · 2020
- Descendant · cites it directly · 3 of its ownK132641 Modified Trevo Provue RetrieverConcentric Medical, Inc. · 2014 · Recalled
- Descendant · 2 generations on · 2 of its ownK211338 EMBOTRAP III Revascularization DeviceNeuravi, Ltd. · 2021
- Descendant · 2 generations on · 1 of its ownK212908 EmboTrap II Revascularization Device, EMBOTRAP III Revascularization…Neuravi, Ltd. · 2021
Showing 5 of 10 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 10 · See all- K173452EmboTrap ll Revascularization DeviceNeuravi, Ltd. · 2018 · cites it directly4descendants
- K193063EMBOTRAP III Revascularization DeviceNeuravi, Ltd. · 2020 · 2 generations on3descendants
- K132641Modified Trevo Provue RetrieverConcentric Medical, Inc. · 2014 · cites it directly3descendants
- K211338EMBOTRAP III Revascularization DeviceNeuravi, Ltd. · 2021 · 2 generations on2descendants
- K212908EmboTrap II Revascularization Device, EMBOTRAP III Revascularization DeviceNeuravi, Ltd. · 2021 · 2 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K003410 | Concentric Retriever, Model 90030 | Concentric Medical, Inc. | 2001 | 1 |
| −4 | K030476 | Modified Concentric Retriever, Model 90037 | Concentric Medical, Inc. | 2003 | 2 |
| −3 | K033736 | Merci Retriever, Models 90065, 90066 | Concentric Medical, Inc. | 2004 | — |
| −2 | K063774 | Modification to Merci Retriever, Models X5 and X6 | Concentric Medical, Inc. | 2007 | — |
| −1 | K120961 | Trevo Retriever | Concentric Medical, Inc. | 2012 | 1 |
| 0 (this device) | K122478 | Modified Trevo Retriever | Concentric Medical, Inc. | 2012 | — |
| +1 | K173452 | EmboTrap ll Revascularization Device | Neuravi, Ltd. | 2018 | — |
| +2 | K193063 | EMBOTRAP III Revascularization Device | Neuravi, Ltd. | 2020 | — |
| +1 | K132641 | Modified Trevo Provue Retriever | Concentric Medical, Inc. | 2014 | 4 |
| +2 | K211338 | EMBOTRAP III Revascularization Device | Neuravi, Ltd. | 2021 | — |
| +2 | K212908 | EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device | Neuravi, Ltd. | 2021 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2014 | 2 | 0 |
| 2015 | 2 | 0 |
| 2018 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 2 | 0 |
| 2022 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NRY device
- #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K120961 | Trevo Retriever | 2012 |
What descends from it? (10)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 11 years and passes through 1 company; a new generation was cleared every 1.8 years on median.
- 3 of the 6 ancestors have a recall of any class.
- Of its descendants, K173452 (Neuravi, Ltd., 2018) has gone furthest, with 4 descendants of its own.
- 1 other device also cites its predicate K120961.
How does its category compare?
All NRY devicesNRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · NRY
15in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NRY
129in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NRY
4in 2020
Class I (4 since 2007) Class II/III not classified
Adverse event reports per year · NRY
565in 2025
MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 5 | 94 | 0 | 13 |
| 2008 | 2 | — | 0 | 18 |
| 2009 | 2 | — | 0 | 57 |
| 2010 | 1 | — | 1 | 289 |
| 2011 | 2 | — | 0 | 263 |
| 2012 | 4 | 90 | 0 | 366 |
| 2013 | 0 | — | 1 | 405 |
| 2014 | 4 | 140 | 0 | 428 |
| 2015 | 6 | 128 | 0 | 598 |
| 2016 | 5 | 75 | 0 | 497 |
| 2017 | 3 | 185 | 4 | 432 |
| 2018 | 11 | 156 | 0 | 415 |
| 2019 | 7 | 89 | 0 | 650 |
| 2020 | 6 | 125 | 4 (4) | 703 |
| 2021 | 9 | 80 | 0 | 688 |
| 2022 | 3 | 129 | 0 | 549 |
| 2023 | 8 | 112 | 0 | 711 |
| 2024 | 8 | 165 | 0 | 641 |
| 2025 | 15 | 129 | 0 | 565 |
| 2026 | 14 | 147 | 2 | — |
What is it indicated for?
The Modified Trevo Retriever is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K122478 · printed Nov 6, 2026
Cite this page
510(k) Report. “K122478: Modified Trevo Retriever.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122478
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026